In vitro activity of BAL9141 against clinical isolates of gram-negative bacteria

Author： Issa N.C.   Rouse M.S.   Piper K.E.   Wilson W.R.   Steckelberg J.M.   Patel R.  

Publisher： Elsevier

ISSN： 0732-8893

Source： Diagnostic Microbiology and Infectious Disease, Vol.48, Iss.1, 2004-01, pp. : 73-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Preventative and Therapeutic Potential of Lipopolysaccharide Derived from Edible Gram-Negative Bacteria to Various Diseases

By  

Current Drug Therapy, Vol. 3, Iss. 1, 2008-01 ,pp. : 26-32

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Gram-Negative Folliculitis in Patients with Acne

By Böni R.   Nehrhoff B.  

American Journal of Clinical Dermatology, Vol. 4, Iss. 4, 2003-01 ,pp. : 273-276

Adis International

Access to resources Recommend Favorite

The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002

By Jones M.E.   Blosser-Middleton R.S.   Thornsberry C.   Karlowsky J.A.   Sahm D.F.  

Diagnostic Microbiology and Infectious Disease, Vol. 47, Iss. 4, 2003-12 ,pp. : 579-586

Elsevier

Access to resources Recommend Favorite

In vitro pharmacodynamic activity of gatifloxacin, gemifloxacin, moxifloxacin and levofloxacin against Streptococcus pneumoniae containing specific mutations in DNA gyrase and topoisomerase IV

By Garrison M.W.   Schimmels J.A.   Madaras-Kelly K.J.  

Diagnostic Microbiology and Infectious Disease, Vol. 47, Iss. 4, 2003-12 ,pp. : 587-593

Elsevier

Access to resources Recommend Favorite

In vitro interactions of licensed and novel antifungal drugs against Fusarium spp

By Ortoneda M.   Capilla J.   Javier Pastor F.   Pujol I.   Guarro J.  

Diagnostic Microbiology and Infectious Disease, Vol. 48, Iss. 1, 2004-01 ,pp. : 69-71

Elsevier

Access to resources Recommend Favorite